期刊文献+

93例食管癌根治术后局部复发预后因素分析 被引量:9

Prognosis analysis of esophageal carcinoma patients with tumor Ioco-regional recurrence after curative surgery
原文传递
导出
摘要 目的 探讨食管癌根治术后局部复发患者的放射治疗疗效和预后影响因素.方法 回顾性分析食管癌根治术后局部区域复发行放射治疗93例患者的临床特点,结合随访资料进行预后因素分析,用Kaplan-Meier法和Logrank法分析比较生存率,用Cox模型进行多因素回归分析.结果 全组患者中位生存时间11.0个月(95%CI 9.4~12.6个月),1、2、3年累积生存率分别为40.9%、10.1%和6.7%.单因素分析显示:患者年龄、PS评分、是否放化疗联合治疗、放射治疗剂量与预后相关;原发灶部位、术后复发间隔时间、以及转移灶数目均不影响预后.Cox模型多因素回归分析显示仅是否放化疗联合治疗、放射治疗剂量为独立预后因素.结论 食管癌根治术后复发放射治疗可以使部分患者生存时间延长,积极放化疗联合治疗、放射治疗剂量≥60 Gy者预后好. Objective To evaluate the outcome of radiotherapy for recurrent esophageal cancer after surgery and to determine the prognostic factors. Methods From Jan 2004 to Dec 2009, 93 patients of esophageal carcinoma with loco-regional recurrence as the first site of failure after surgery were retrospectively reviewed. Kaplan-Meier method was used to analyze the survival. Logrank test was used to evaluate the difference between the groups. Multivariate survival analysis was conducted using a Cox proportional hazard regression model with a backward stepwise procedure. Results The overall survival rates at 1, 2 and 3 years were 40. 9% , 10. 1% and 6. 7% ,respectively,but with a median survival time of 11.0 months(95% CI 9. 4-12. 6) . In univariate analysis, age,PS, radiation dose and retreatment methods were independent prognostic factors. In multivariate analysis, only radiation dose and retreatment methods were independent prognostic factors for overall survival. Conclusions The prognosis of patients with postoperative loco-regional recurrence of esophageal cancer is poor. However, a long-term survival maybe expected by definitive chemoradiotherapy.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2010年第3期333-335,共3页 Chinese Journal of Radiological Medicine and Protection
关键词 食管肿瘤 术后复发 放射疗法 预后 Esophageal cancer Recurrence after surgery Radiotherapy Prognosis
  • 相关文献

参考文献7

  • 1Isono K, Onoda S, Ishikawa T, et al. Studies on the causes of deaths from esophageal carcinoma. Cancer, 1982, 49 (10) :2173.
  • 2Lee SJ, Lee KS, Yim YJ, et al. Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol, 2005, 60(5) : 547-554.
  • 3Seitz JF, Duffaud F, Dahan L, et al. Adenocarcinomas of the distal esophagus and gastric cardia: what chemotherapy or chemoradiotherapy for recurrent or metastatic disease? Cancer Radiother, 2001, 5(Suppl 1): 107-112.
  • 4Shioyama Y, Nakamura K, Ohga S, et al. Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors. Jpn J Clin Oneol, 2007,37(12) :918-923.
  • 5Nemoto K, Ariga H, Kakuto Y, et al. Radiotherapy for tocoregionally recurrent esophageal cancer after surgery. Radiother Oncol, 2001,61 : 165-168.
  • 6Jingu K, Nemoto K, Matsushita H, et al. Results of radiotherapy therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouraci lfor postoperative locoregional recurrent esophageal cancer. BMC Cancer, 2006,6( 1 ) :50-59.
  • 7Nemoto K, Matsushita H, Ogawa Y, et al. Radiotherapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracll for untreated and recurrent esophageal cancer. Am J Clin 0ncol,2003,26( 1 ) :46-49.

同被引文献98

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部